Chemical Compound

Lunacalcipol

CAS Registry Number 250384-82-8
Lunacalcipol chemical structure
Primary Record

Lunacalcipol

In stock
7,081 g
Purity
98.7 %
CAS
250384-82-8

Compound Identifiers & Properties

CAS
250384-82-8
PubChem CID
10672195
SMILES
C[C@H](C/C=C/S(=O)(=O)C(C)(C)C)C1=CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
Canonical SMILES
C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)C/C=C/S(=O)(=O)C(C)(C)C)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O

Names & Synonyms

  • Lunacalcipol
  • lunacalcipolum
  • Lunacalcipol [USAN]
  • CTA018
  • Lunacalcipol [USAN:INN]
  • UNII-XN4TL6M50Z
  • CTA-018
  • XN4TL6M50Z
  • LUNACALCIPOL [INN]
  • CTA 018
  • RefChem:800130
  • Lunacalcipol (USAN/INN)
  • D00DYK
  • LUNACALCIPOL [WHO-DD]
  • 250384-82-8
  • orb1696307
  • CTA018/MT2832
  • CHEMBL2105705
  • SCHEMBL29376374
  • GTPL11382
  • CHEBI:177662
  • GH-1623E-diene-25SO2-2
  • BDBM50023361
  • AKOS040752736
  • MT-2832
  • CID10672195
  • CID 10814396
  • HY-14863
  • CS-0003602
  • (1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
  • J1.180.657K
  • D09928
  • Q27293916
  • Lunacalcipol (intravenous, secondary hyperparathyroidism)
  • CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma
  • Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma
  • (5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol
  • 1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-
  • Vitamin D analogs (secondary hyperparathyroidism), Johns Hopkins/Cytochroma
  • CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma
  • (1R,3S,5Z)-5-((2E)-2-((3aS,7aS)-1-((E,2R)-5-tert-butylsulfonylpent-4-en-2-yl)-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene)ethylidene)-4-methylidenecyclohexane-1,3-diol
  • (1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
  • (1R,3S,5Z)-5-{2-[(3aS,7E,7aS)-3a-methyl-3-[(2R,4E)-5-(2-methylpropane-2-sulfonyl)pent-4-en-2-yl]-3a,4,5,6,7,7a-hexahydro-1H-inden-7-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol
  • (5Z,7E,16Z,23E)-(1S,3R)-25-NOR-25-T-BUTYLSULFONYL-9,10-SECO-5,7,10(19),16,23-CHOLESTAPENTAENE-1,3-DIOL
  • (5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol
  • (5Z,7E,23E)-25,26,27-Trinor-24-(tert-butylsulfonyl)-9,10-secocholesta-5,7,10(19),16,23-pentene-1alpha,3beta-diol
  • (5Z,7E,23E)-4-Methylene-24-(tert-butylsulfonyl)-19-nor-9,10-secochola-5,7,16,23-tetraene-1alpha,3beta-diol
  • 1,3-CYCLOHEXANEDIOL, 5-((2E)-2-((3AS,7AS)-1-((1R,3E)-4-((1,1-DIMETHYLETHYL)SULFONYL)-1-METHYL-3-BUTEN-1-YL)-3,3A,5,6,7,7A-HEXAHYDRO-7A-METHYL-4H-INDEN-4-YLIDENE)ETHYLIDENE)-4-METHYLENE-, (1R,3S,5Z)-